Skip to main content

Advertisement

SpringerLink
Log in

Hematopoietic growth factors in the treatment of patients with HIV infection

  • Published:
Biotherapy

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Donahue RE, Johnson MM, Zon LI, Clark SC, Groopman JE. Supression in vitro hematopoiesis following human immunodeficiency virus infection. Nature 1987; 326: 200–03.

    Article  PubMed  Google Scholar 

  2. Folks TM, Kessler SW, Orenstein JMet al. Infection and replication of HIV-1 in purifed progenitor cells of normal human bone marrow. Science 1988; 242: 919–22.

    PubMed  Google Scholar 

  3. Stella CG, Ganser A, Hoelzer D. Defective in vitro growth of hematopoietic progenitor cells in AIDS. J Clin Invest 1987; 80: 286–93.

    PubMed  Google Scholar 

  4. Kopelman RG, Zolla-Pazner S. Association of human immunodeficiency virus infection and autoimmune phenomena. Am J Med 1988; 84: 82–88.

    Article  PubMed  Google Scholar 

  5. Morris L, Distenfeld A, Amorosi E, Karpatkin S. Autoimmune thrombocytopenia purpura in homosexual men. Ann Intern Med 1982; 96: 714–17.

    PubMed  Google Scholar 

  6. Zon LI, Groopman JE. Hematologic manifestation of the human immune deficiency virus (HIV). Semin Hematol 1988; 25: 208–18.

    PubMed  Google Scholar 

  7. Perkocha LA, Rodgers GM. Hematologic aspects of human immunodeficiency virus infection. Am J Hematol 1988; 29: 94–105.

    PubMed  Google Scholar 

  8. Mitsuyasu RT, Lee KJ. T-lymphocyte colony assay in patients with Kaposi's sarcoma and AIDS. Exp Hematol 1998; 12: 216.

    Google Scholar 

  9. Hammer SM, Gills JM, Groopman JE, Rose RM. In vitro modification of human immunodeficiency virus infection by granulocyte-macrophage colony-stimulating factor and gamma interferon. Proceedings National Academy of Science USA 1986; 83: 8734–38.

    Google Scholar 

  10. Winklestein A, Klein RS, Evans TLet al. Defective in vitro T-cell colony formation in the acquired immunodeficiency syndrome. J Immunol 1985; 134: 151–6.

    PubMed  Google Scholar 

  11. Gasson JC, Weisbart RH, Kaufman SEet al. Purified human granulocyte-macrophage colony-stimulating factor: Direct action on neutrophils. Science 1984; 226: 1339–42.

    PubMed  Google Scholar 

  12. Weisbart RH, Golde DW. Physiology of granulocyte and macrophage colony-stimulating factors in host defense. Hematol Oncol Clin North America 1989; 3: 401–9.

    Google Scholar 

  13. Metcalf D. The granulocyte-macrophage colony-stimulating factors. Science 1985; 229: 16–22.

    PubMed  Google Scholar 

  14. Clark SC, Kamen R. The human hematopoietic colony-stimulating factors. Science 1987; 236: 1229–37.

    PubMed  Google Scholar 

  15. Donahue RE, Wang EA, Stone DKet al. Stimulation of hematopoiesis in primates by continuous infusion of recombinant human GM-CSF. Nature 1986; 321: 872–5.

    Article  PubMed  Google Scholar 

  16. Mayer P, Lam C, Obenaus Het al. Recombinant human GM-CSF induces leukocytosis and activates peripheral blood polymorphonuclear neutrophils in nonhuman primates. Blood 1987; 70: 206–213.

    PubMed  Google Scholar 

  17. Monroy RL, Skelly RR, Taylor Pet al. Recovery from severe hematopoietic suppression using recombinant human granulocyte-macrophage colony-stimulating factor. Exp Hematol 1988; 16: 344–48.

    PubMed  Google Scholar 

  18. Nienhuis AW, Donahue RE, Karlsson Set al. Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model. J Clin Invest 1987; 80: 573–7.

    PubMed  Google Scholar 

  19. Koyanagi Y, O'Brien WA, Zhao JQet al. Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science 1988; 241: 1673–75.

    PubMed  Google Scholar 

  20. Folks TM, Justement J, Kinter Aet al. Cytokine-induced expression of HIV-1 in a chronically infected promonocytic cell line. Science 1987; 238: 800–2.

    PubMed  Google Scholar 

  21. Cortes EB, Koeflìer HP, Mitsuyasu RT. Effect of cytokines on HIV replication of infected human myelomonocytes cell lines (Abstract). XXII Congress Internatl Soc Hematol 1988.

  22. Hammer SM, Gillis JM. Synergistic activity of granulocyte-macrophage colony-stimulating factor and 3′-azido-3′deoxythymidine against human immunodeficiency virus in vitro. Antimicrob Agents Chemother 1987; 31: 1046–50.

    PubMed  Google Scholar 

  23. Perno C, Yarchoan R, Cooney DAet al. Replication of human immunodeficiency virus in monocytes. GM-CSF potentiates viral production yet enhances the antiviral effect mediated by AZT and other dideoxynucleoside congeners of thymidine. J Exp Med 1989; 169: 933–51.

    Article  PubMed  Google Scholar 

  24. Bhalla K, Birkhofer M, Grant S, Graham G. The effect of recombinant human GM-CSF on AZT-mediated biochemical and cytotoxic effects on normal human myeloid progenitor cells. Exp Hematol 1989; 17: 17–20.

    PubMed  Google Scholar 

  25. Groopman JE, Mitsuyasu RT, DeLeo MJet al. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N Eng J Med 1987; 317: 593–8.

    Google Scholar 

  26. Baldwin GC, Gasson JC, Quan SGet al. GM-CSF enhances neutrophil function in AIDS patients. Proc Natl Acad Sci USA. 1988; 85: 2763–66.

    PubMed  Google Scholar 

  27. Mitsuyasu R, Levine J, Miles SAet al. Effects of long term subcutaneous (SC) administration of recombinant granulocyte-macrophage colony-stimulating factor (GMCSF) in patients with HIV-related leukopenia (Abstract). Blood 1988; 72 (suppl 1): 357.

    Google Scholar 

  28. Krown SE, O'Boyle K, Gold JWMet al. Recombinant human granulocyte-macrophage colony-stimulating factor: A phase I trial in neutropenic AIDS patients. V Intl Conf on AIDS, 1989: 403.

  29. Levine JD, Allan JD, Tessitore JHet al. Granulocyte-macrophage colony stimulating factor ameliorates the neutropenia induced by azidothymidine in AIDS/ARC patients. (Abstract) Proc Am Soc Clin Onc 1989; 8: 1.

    Google Scholar 

  30. Grossberg HS, Bonnem EM, Buhles WC. GM-CSF with ganciclovir for the treatment of CMV retinitis in AIDS (Letter). N Engl J Med 1989; 320: 1560.

    Google Scholar 

  31. Kaplan LD, Kahn JO, Grossberg H, Volberding PA. Chemotherapy with or without rGM-CSF in patients with AIDS-associated non-Hodgkin's lymphoma (NHL) (Abstract). V International Conference on AIDS. 1989; 334.

  32. Walsh C, Wernz J, Laubenstein Let al. Phase I study of mBACOD and GM-CSF in AIDS-associated non-Hodgkin's lymphoma (NHL): Preliminary results. Blood 1989; 74: 126a (abstract).

    Google Scholar 

  33. Gill PS. Levine AM, Krailo Met al. AIDS-related malignant lymphoma: Results of prospective treatment trial. J Clin Oncol 1987; 5: 1322–28.

    PubMed  Google Scholar 

  34. Kovacs JA, Deyton L, Davey Ret al. Combined zidovudine and interferon alpha therapy in patients with Kaposi's sarcoma and AIDS. Ann Intern Med 1989; 111: 280–7.

    PubMed  Google Scholar 

  35. Krown S, Bundow D, Gansbacher B et al. Interferon alpha + AZT in AIDS-associated Kaposi's sarcoma: Final results of a phase I trial. V International Conference on AIDS, 1989, 414.

  36. Fischl M, Reese J, Dearmas L et al. Phase I study of interferon-alpha and AZT in patients with AIDS-related Kaposi's sarcoma. IV International Conference AIDS, 1988; 253.

  37. Fischl MA, Uttamchandani R, Gagnon Set al. Phase I study of interferon alpha-2b (Intern), zidovudine and rGM-CSF in patients with AIDS-associated Kaposi's sarcoma (Abstract). V International Conference on AIDS 1989; 342.

  38. Scadden D, Bering H, Levine Jet al. Combined AZT/Interferon-alpha/GM-CSF for AIDS-associated Kaposi's sarcoma (KS). Blood 1989; 74: 127 (abstract).

    Google Scholar 

  39. Rudnick SAet al. Human recombinant erythropoietin (r-HUEPO): A double-blind, placebo-controlled study in AIDS patients with anemia induced by disease and AZT Proc Am Soc Clin Onc 1989; 8: 2 (abstract).

    Google Scholar 

  40. Rarick M, Wilson E, Bernstein-Singer M et al. Double-blind placebo controlled study of recombinant human erythropoietin in AIDS patients with anemia caused by HIV infection and zidovudine. V International Conference AIDS 1989; 195.

  41. Gabrilove JL, Jakubowski A, Scher Het al. Effect of granulocyte colony stimulating factor on neutropenia and associated morbidity of chemotherapy for transitional cell carcinoma of the urothelium. N Engl J Med 1988; 318: 1414.

    PubMed  Google Scholar 

  42. Hammond WP, Price TH, Souza LMet al. Cyclic hematopoiesis treated with recombinant human G-CSF (Abstract). Blood 1988; 72 (suppl 1): 388.

    Google Scholar 

  43. Gabrilove JL, Jakubowski A. Granulocyte colony-stimulating factor: Preclinical and clinical studies. Hematol Onc Clin North Amer. 1989; 3: 429–40.

    Google Scholar 

  44. Miles SA, Mitsuyasu R, Fink Net al. Recombinant G-CSF and recombinant erythropoietin may abrogate the neutropenia and anemia of AIDS and may allow resumption of AZT (Abstract). V International Conference on AIDS 1989; 550.

Download references

Author information

Authors and Affiliations

  1. Division of Hematology-Oncology, AIDS Clinical Research Center, UCLA School of Medicine, 90024-1793, Los Angeles, CA, USA

    Ronald T. Mitsuyasu

Authors
  1. Ronald T. Mitsuyasu
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mitsuyasu, R.T. Hematopoietic growth factors in the treatment of patients with HIV infection. Biotherapy 2, 173–181 (1990). https://doi.org/10.1007/BF02173456

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02173456

Key words

Search

Navigation